Search by Drug Name or NDC

    NDC 00169-1912-01 Zegalogue 0.6 mg/.6mL Details

    Zegalogue 0.6 mg/.6mL

    Zegalogue is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is DASIGLUCAGON.

    Product Information

    NDC 00169-1912
    Product ID 0169-1912_48d68219-2ba1-426f-a5a0-0cc35e69ff19
    Associated GPIs
    GCN Sequence Number 082098
    GCN Sequence Number Description dasiglucagon HCl AUTO INJCT 0.6 MG/0.6 SUBCUT
    HIC3 M4G
    HIC3 Description AGENTS TO TREAT HYPOGLYCEMIA (HYPERGLYCEMICS)
    GCN 49403
    HICL Sequence Number 047227
    HICL Sequence Number Description DASIGLUCAGON HCL
    Brand/Generic Brand
    Proprietary Name Zegalogue
    Proprietary Name Suffix n/a
    Non-Proprietary Name dasiglucagon
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 0.6
    Active Ingredient Units mg/.6mL
    Substance Name DASIGLUCAGON
    Labeler Name Novo Nordisk
    Pharmaceutical Class Antihypoglycemic Agent [EPC], Glucagon Receptor Agonists [MoA], Increased Glycogenolysis [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA214231
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-1912-01 (00169191201)

    NDC Package Code 0169-1912-01
    Billing NDC 00169191201
    Package 1 CONTAINER in 1 PACKAGE (0169-1912-01) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2023-06-26
    NDC Exclude Flag N
    Pricing Information N/A